Rhinocort (Budesonide) - Summary

RHINOCORT SUMMARY

Budesonide, the active ingredient of RHINOCORT AQUA® Nasal Spray, is an anti-inflammatory synthetic corticosteroid.

RHINOCORT AQUA Nasal Spray is indicated for the management of nasal symptoms of seasonal or perennial allergic rhinitis in adults and children six years of age and older.

See all Rhinocort indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Rhinocort (Budesonide)

Hay Fever (Allergic Rhinitis)
Source: MedicineNet Allergic Cascade Specialty [2016.10.07]
Title: Hay Fever (Allergic Rhinitis)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 10/7/2016 12:00:00 AM

more news >>

Published Studies Related to Rhinocort (Budesonide)

Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis. [2015]
remission in patients with ulcerative proctitis or ulcerative proctosigmoiditis... CONCLUSIONS: Budesonide rectal foam was well tolerated and more efficacious than

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. [2015]
budesonide MMX in patients with mild-to-moderate active UC... CONCLUSION: This pooled analysis showed that budesonide MMX 9 mg is efficacious,

Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. [2013]
exacerbation of asthma... CONCLUSION: On the basis of nebulized short-acting bronchodilators, addition of

Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler(R) in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. [2012.01.01]
Background: The use of budesonide/formoterol as both maintenance and reliever therapy in asthma is recommended in many countries; however, there are limited data available for the Asian patient population. Objective: This study aimed to evaluate the short-term safety and tolerability of a fixed high-dose combination of the inhaled corticosteroid budesonide and the long-acting beta(2)-adrenoceptor agonist formoterol with that of the beta(2)-agonist terbutaline for acute symptom relief in Japanese adults with persistent asthma who were already receiving a combination of budesonide/formoterol maintenance therapy...

Abatacept for Crohn's disease and ulcerative colitis. [2012]
modulator, in Crohn's disease (CD) and ulcerative colitis (UC) is unknown... CONCLUSIONS: The studies showed that abatacept is not efficacious for the

more studies >>

Clinical Trials Related to Rhinocort (Budesonide)

Assess the Efficacy and Safety of Rhinocort Aqua [Completed]
The purpose of this study is to compare Rhinocort with placebo in pediatric subjects aged 2-5 years with allergic rhinitis to study effects on nasal symptoms such as sneezing, runny and stuffy noses.

Rhinocort Aqua Versus Placebo and Fluticasone Propionate [Completed]
The purpose of this study is to compare once daily treatment with Rhinocort against placebo and Fluticasone Propionate at reliving the nasal symptoms of seasonal allergic rhinitis.

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer [Completed]
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of budesonide may keep lung cancer from forming in patients with lung nodules. PURPOSE: This randomized phase II trial is studying how well inhalation budesonide works in treating patients with lung nodules who are at high risk of lung cancer.

Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide [Completed]
Glucocorticosteroids recently have been shown to have non-genomic actions that are plasma membrane-mediated and do not require gene transcription and translation. One of these non-genomic effects is the inhibition of adrenergic agonist transport into airway vascular smooth muscle cells with an increase of adrenergic agonist concentrations at adrenergic receptor sites and enhance the physiological effects of endogenous adrenergic agonists (e. g. locally released norepinephrine from noradrenergic neurons) or exogenous adrenergic agonists (e. g. inhaled beta-adrenergic agonists).

Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR [Completed]
The primary objective of this study was to compare the relative efficacy of Budesonide administered via Captisol-Enabled Budesonide nasal solution and Rhinocort Aqua in patients with seasonal allergic rhinitis (SAR) exposed to controlled ragweed pollen using an EEC model.

more trials >>

Reports of Suspected Rhinocort (Budesonide) Side Effects

Drug Dose Omission (66),  Malaise (60),  Dyspnoea (42),  Intentional Drug Misuse (28),  Sinusitis (28),  Asthma (27),  Gastrooesophageal Reflux Disease (27),  OFF Label USE (25),  Drug Ineffective (22),  Nasal Congestion (21), more >>

PATIENT REVIEWS / RATINGS / COMMENTS

Rhinocort review by 33 year old male patient
		Rating
Overall rating:
Effectiveness:		Moderately Effective
Side effects:		Mild Side Effects
		Treatment Info
Condition / reason:		Allergies
Dosage & duration:		1 spray per nostril (dosage frequency: daily) for the period of 3 weeks
Other conditions:		none
Other drugs taken:		none
		Reported Results
Benefits:		Seemed to ease allergic rhinitis symptoms caused by seasonal allergies. Easy administration was a great benefit.
Side effects:		Sneezing and bad taste. Some burning in the nostrils.
Comments:		I had sneezing, dry nasal passages caused by seasonal allergies. Using this product daily seemed to ease my symptoms. I still had some sneezing but the frequency and intensity of sneezing fits was reduced considerably. Administered one spray per nostril prior to going to bed at night. Used product nightly for approximately three weeks.